Drug class
Butyrophenone typical antipsychotic; dopamine D2-receptor antagonist
Mechanism of action
Antagonises dopamine D2 receptors in central dopaminergic pathways, reducing dopaminergic neurotransmission associated with psychotic symptoms. Extrapyramidal and prolactin-related effects are consistent with D2 blockade.
General use cases
- Treatment of schizophrenia and other psychotic disorders in countries where bromperidol is authorised; current availability and exact indications are jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
